Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strategies for the Treatment of Arterial Hypertension: Fixed-Dose Combination (Losartan + Hydrochlorothiazide) vs Monotherapy (Estrataar)
2004-002020-17Phase 4Active
- Sponsor
- Societat Catalana de Medicina Familiar i Comunitària
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of losartan + hydrochlorothiazide in hypertension (HTN) (2 arms), sponsored by Societat Catalana de Medicina Familiar i Comunitària. Primary endpoint: Blood pressure at week 24. Started Dec 2005; status: active.
02
Drugs
losartan + hydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2004-002020-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002020-17.